Sun W, Tao L, Qian C, Xue P, Du S, Tao Y
Front Cell Infect Microbiol. 2025; 14():1386421.
PMID: 39835278
PMC: 11743518.
DOI: 10.3389/fcimb.2024.1386421.
Wu J, Huang E, McMullen M, Singh V, Mrdjen M, Bellar A
Hepatol Commun. 2024; 8(12.
PMID: 39621302
PMC: 11608733.
DOI: 10.1097/HC9.0000000000000547.
Xu B, Song P, Jiang F, Cai Z, Gu H, Gao H
NPJ Biofilms Microbiomes. 2024; 10(1):120.
PMID: 39505908
PMC: 11541592.
DOI: 10.1038/s41522-024-00597-3.
Zahn L, Gannon P, Rajakovich L
Metallomics. 2024; 16(11).
PMID: 39504489
PMC: 11574389.
DOI: 10.1093/mtomcs/mfae049.
Huang Y, Lewis C, Wright C, Schneider K, Kemmitt J, Trumper D
Microbiome Res Rep. 2024; 3(3):30.
PMID: 39421254
PMC: 11480719.
DOI: 10.20517/mrr.2024.14.
Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.
Sharma S, Gilberto V, Levens C, Chatterjee A, Kuhn K, Nagpal P
ACS Pharmacol Transl Sci. 2024; 7(9):2677-2693.
PMID: 39296260
PMC: 11406689.
DOI: 10.1021/acsptsci.4c00102.
Advancements in gene editing technologies for probiotic-enabled disease therapy.
Wang L, Hu J, Li K, Zhao Y, Zhu M
iScience. 2024; 27(9):110791.
PMID: 39286511
PMC: 11403445.
DOI: 10.1016/j.isci.2024.110791.
The Associations Among Gut Microbiota, Branched Chain Amino Acids, and Parkinson's Disease: Mendelian Randomization Study.
Yan Z, Zhao G
J Parkinsons Dis. 2024; 14(6):1129-1138.
PMID: 39177611
PMC: 11380289.
DOI: 10.3233/JPD-240244.
Genetic manipulations of nonmodel gut microbes.
Jin W, Guo C
Imeta. 2024; 3(4):e216.
PMID: 39135697
PMC: 11316930.
DOI: 10.1002/imt2.216.
Gut microbiota-derived fatty acid and sterol metabolites: biotransformation and immunomodulatory functions.
Zhang H, Xie Y, Cao F, Song X
Gut Microbes. 2024; 16(1):2382336.
PMID: 39046079
PMC: 11271093.
DOI: 10.1080/19490976.2024.2382336.
The gut microbiome of farmed Arctic char () is shaped by feeding stage and nutrient presence.
Knobloch S, Skirnisdottir S, Dubois M, Mayolle L, Kolypczuk L, Leroi F
FEMS Microbes. 2024; 5:xtae011.
PMID: 38745980
PMC: 11092275.
DOI: 10.1093/femsmc/xtae011.
Buty and the beast: the complex role of butyrate in Parkinson's disease.
Elford J, Becht N, Garssen J, Kraneveld A, Perez-Pardo P
Front Pharmacol. 2024; 15:1388401.
PMID: 38694925
PMC: 11061429.
DOI: 10.3389/fphar.2024.1388401.
Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology.
Li T, Chen X, Huo D, Arifuzzaman M, Qiao S, Jin W
Cell Host Microbe. 2024; 32(5):661-675.e10.
PMID: 38657606
PMC: 11636940.
DOI: 10.1016/j.chom.2024.04.004.
The Role of Gut Microbiota in Neuromyelitis Optica Spectrum Disorder.
Yao S, Yang X, Cen L, Tan S
Int J Mol Sci. 2024; 25(6).
PMID: 38542152
PMC: 10970017.
DOI: 10.3390/ijms25063179.
Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host.
Vasconcelos Pereira G, Boudaud M, Wolter M, Alexander C, De Sciscio A, Grant E
Cell Host Microbe. 2024; 32(4):527-542.e9.
PMID: 38513656
PMC: 11064055.
DOI: 10.1016/j.chom.2024.03.001.
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice.
Wyss J, Raselli T, Wyss A, Telzerow A, Rogler G, Krupka N
BMC Microbiol. 2024; 24(1):69.
PMID: 38418983
PMC: 10900623.
DOI: 10.1186/s12866-024-03195-7.
A toolbox for genetic manipulation in intestinal .
Yang P, Tian J, Zhang L, Zhang H, Yang G, Ren Y
Synth Syst Biotechnol. 2024; 9(1):43-54.
PMID: 38234413
PMC: 10793094.
DOI: 10.1016/j.synbio.2023.12.005.
Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation.
Arifuzzaman M, Collins N, Guo C, Artis D
Immunity. 2024; 57(1):14-27.
PMID: 38198849
PMC: 10795735.
DOI: 10.1016/j.immuni.2023.12.009.
Alterations of gut microbiota and short-chain fatty acids induced by in the hindgut of Xenocyprinae fishes providing new insights into the relationship among protozoa, gut microbiota and host.
Bu X, Li Z, Zhao W, Zeng Q, Chen Y, Li W
Front Microbiol. 2023; 14:1295456.
PMID: 38075928
PMC: 10702975.
DOI: 10.3389/fmicb.2023.1295456.
Exploitation of microbial activities at low pH to enhance planetary health.
Atasoy M, Alvarez Ordonez A, Cenian A, Djukic-Vukovic A, Lund P, Ozogul F
FEMS Microbiol Rev. 2023; 48(1).
PMID: 37985709
PMC: 10963064.
DOI: 10.1093/femsre/fuad062.